These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 8530609

  • 1. 11 beta-Hydroxysteroid dehydrogenase activity in Cushing's syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome.
    Stewart PM, Walker BR, Holder G, O'Halloran D, Shackleton CH.
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3617-20. PubMed ID: 8530609
    [Abstract] [Full Text] [Related]

  • 2. Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man.
    Palermo M, Shackleton CH, Mantero F, Stewart PM.
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):605-11. PubMed ID: 8977758
    [Abstract] [Full Text] [Related]

  • 3. Mineralocorticoid excess and inhibition of 11 beta-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome.
    Walker BR, Campbell JC, Fraser R, Stewart PM, Edwards CR.
    Clin Endocrinol (Oxf); 1992 Dec; 37(6):483-92. PubMed ID: 1337504
    [Abstract] [Full Text] [Related]

  • 4. 11 beta-Hydroxysteroid dehydrogenase deficiency and glucocorticoid status in patients with alcoholic and non-alcoholic chronic liver disease.
    Stewart PM, Burra P, Shackleton CH, Sheppard MC, Elias E.
    J Clin Endocrinol Metab; 1993 Mar; 76(3):748-51. PubMed ID: 8445034
    [Abstract] [Full Text] [Related]

  • 5. Absence of Cushingoid phenotype in a patient with Cushing's disease due to defective cortisone to cortisol conversion.
    Tomlinson JW, Draper N, Mackie J, Johnson AP, Holder G, Wood P, Stewart PM.
    J Clin Endocrinol Metab; 2002 Jan; 87(1):57-62. PubMed ID: 11788623
    [Abstract] [Full Text] [Related]

  • 6. Association of hypertension and hypokalemia with Cushing's syndrome caused by ectopic ACTH secretion: a series of 58 cases.
    Torpy DJ, Mullen N, Ilias I, Nieman LK.
    Ann N Y Acad Sci; 2002 Sep; 970():134-44. PubMed ID: 12381548
    [Abstract] [Full Text] [Related]

  • 7. Hypertension and the cortisol-cortisone shuttle.
    Quinkler M, Stewart PM.
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2384-92. PubMed ID: 12788832
    [Abstract] [Full Text] [Related]

  • 8. Cortisol inactivation overload: a mechanism of mineralocorticoid hypertension in the ectopic adrenocorticotropin syndrome.
    Ulick S, Wang JZ, Blumenfeld JD, Pickering TG.
    J Clin Endocrinol Metab; 1992 May; 74(5):963-7. PubMed ID: 1569172
    [Abstract] [Full Text] [Related]

  • 9. [Decreased activity of 11-beta-hydroxysteroid dehydrogenase in patients with Cushing's syndrome].
    Stiefel P, Jiménez L, García-Morillo JS, Leal A, Villar J, Carneado J.
    Med Clin (Barc); 2000 Jun 17; 115(3):90-2. PubMed ID: 10965482
    [Abstract] [Full Text] [Related]

  • 10. 11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess.
    White PC, Mune T, Agarwal AK.
    Endocr Rev; 1997 Feb 17; 18(1):135-56. PubMed ID: 9034789
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Aron DC, Raff H, Findling JW.
    J Clin Endocrinol Metab; 1997 Jun 17; 82(6):1780-5. PubMed ID: 9177382
    [Abstract] [Full Text] [Related]

  • 12. Apparent mineralocorticoid excess causing hypertension and hypokalemia in children.
    New MI, Stoner E, DiMartino-Nardi J.
    Clin Exp Hypertens A; 1986 Jun 17; 8(4-5):751-72. PubMed ID: 3463439
    [Abstract] [Full Text] [Related]

  • 13. Tissue-specific Cushing's syndrome, 11beta-hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action.
    Stewart PM.
    Eur J Endocrinol; 2003 Sep 17; 149(3):163-8. PubMed ID: 12943516
    [Abstract] [Full Text] [Related]

  • 14. Androgen secretion in ectopic ACTH syndrome and in Cushing's disease: modifications before and after surgery.
    Barbetta L, Dall'Asta C, Re T, Colombo P, Travaglini P, Ambrosi B.
    Horm Metab Res; 2001 Oct 17; 33(10):596-601. PubMed ID: 11607879
    [Abstract] [Full Text] [Related]

  • 15. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E, Arvat E, Ramunni J, Colao A, Gianotti L, Deghenghi R, Lombardi G, Camanni F.
    J Clin Endocrinol Metab; 1997 Aug 17; 82(8):2439-44. PubMed ID: 9253314
    [Abstract] [Full Text] [Related]

  • 16. Human kidney 11 beta-hydroxysteroid dehydrogenase: regulation by adrenocorticotropin?
    Diederich S, Quinkler M, Miller K, Heilmann P, Schoneshofer M, Oelkers W.
    Eur J Endocrinol; 1996 Mar 17; 134(3):301-7. PubMed ID: 8616526
    [Abstract] [Full Text] [Related]

  • 17. Reduced 11beta-hydroxysteroid dehydrogenase activity in patients with the nephrotic syndrome.
    Vogt B, Dick B, N'Gankam V, Frey FJ, Frey BM.
    J Clin Endocrinol Metab; 1999 Feb 17; 84(2):811-4. PubMed ID: 10022459
    [Abstract] [Full Text] [Related]

  • 18. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.
    Tsilchorozidou T, Honour JW, Conway GS.
    J Clin Endocrinol Metab; 2003 Dec 17; 88(12):5907-13. PubMed ID: 14671189
    [Abstract] [Full Text] [Related]

  • 19. Apparent cortisone reductase deficiency: a unique form of hypercortisolism.
    Phillipov G, Palermo M, Shackleton CH.
    J Clin Endocrinol Metab; 1996 Nov 17; 81(11):3855-60. PubMed ID: 8923828
    [Abstract] [Full Text] [Related]

  • 20. Does central obesity reflect "Cushing's disease of the omentum"?
    Bujalska IJ, Kumar S, Stewart PM.
    Lancet; 1997 Apr 26; 349(9060):1210-3. PubMed ID: 9130942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.